Snipr Biome to collaborate with US cancer hospital

The Danish company will examine the effect of new CRISPR therapies as a treatment for immune therapy side effects alongside the MD Anderson Cancer Center.
Snipr Biome CEO Christian Grøndahl | Photo: EY / PR
Snipr Biome CEO Christian Grøndahl | Photo: EY / PR
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT

Biotech company Snipr Biome has found a partner to help develop new treatments using CRISPR technology, which targets the human microbiome.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading